Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1218
| Despition | Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1231 | Prominin 1 Blocking Peptide (AC1231) | 250 µg | inquiry |
| ACPP-1229 | Mouse Leptin Protein (AC1229) | 200 µg | inquiry |
| ACPP-1225 | POMT1 Blocking Peptide (AC1225) | 250 µg | inquiry |
| ACPP-1433 | Human Interleukin 6 (Active) Protein (AC1433) | 100 µg | inquiry |
| ACPP-1566 | Human STMN1 Protein (AC1566) | 5 µg | inquiry |
| ACPP-1517 | Human PGRN Protein (AC1517) | 2 µg | inquiry |
| ACPP-1639 | Human NGFR Protein (AC1639) | 2 µg | inquiry |
| ACPP-1247 | GSK3 beta Blocking Peptide (AC1247) | 250 µg | inquiry |
| ACPP-1265 | EDG8 Blocking Peptide (AC1265) | 250 µg | inquiry |
| ACPP-1224 | LAMP1 Blocking Peptide (AC1224) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.